Concurrent Chemo-Proton Therapy Using Adaptive Planning for Unresectable Stage 3 Non-Small Cell Lung Cancer: A Phase 2 Study
Open Access
- 20 November 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 109 (5), 1359-1367
- https://doi.org/10.1016/j.ijrobp.2020.11.035
Abstract
No abstract availableFunding Information
- Uehara Memorial Foundation
- Japan Society for the Promotion of Science (15H05675)
This publication has 46 references indexed in Scilit:
- Comparative efficacy and safety for different chemotherapy regimens used concurrently with thoracic radiation for locally advanced non-small cell lung cancer: a systematic review and network meta-analysisRadiation Oncology, 2019
- A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008LBritish Journal of Cancer, 2018
- Long-term results of S-1 plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancerCancer Chemotherapy and Pharmacology, 2018
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 studyThe Lancet Oncology, 2015
- Long-Term Outcome of Proton Therapy and Carbon-Ion Therapy for Large (T2a–T2bN0M0) Non–Small-Cell Lung CancerJournal of Thoracic Oncology, 2013
- Incorporating Bevacizumab and Erlotinib in the Combined-Modality Treatment of Stage III Non–Small-Cell Lung Cancer: Results of a Phase I/II TrialJournal of Clinical Oncology, 2012
- The combination of hyperthermia or chemotherapy with gimeracil for effective radiosensitizationStrahlentherapie und Onkologie, 2012
- S-1 Plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Multi-Institutional Phase II Trial (West Japan Thoracic Oncology Group 3706)Journal of Thoracic Oncology, 2011
- Phase 2 study of high‐dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancerCancer, 2011
- Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non–small-cell lung cancer: A randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 2001